Kyle Cruz is currently the Director of Program Management in Oncology R&D at AstraZeneca. They previously held the position of Manager and Project Lead in Strategy & Innovation at LifeLabs Medical Laboratory Services from 2017 to 2019. Additionally, Kyle worked as a Senior Consultant and then as a Manager in Strategy, Risk, and Transactions at Deloitte Canada from 2021 to 2024. Kyle is pursuing a Master of Business Administration (MBA) at Ivey Business School at Western University and a Bachelor of Science (B.Sc.) in Medical Radiation Science, with a focus on Nuclear Medicine, at the University of Toronto.
This person is not in the org chart
This person is not in any teams
This person is not in any offices